Sierra SnowBlog Oct. 2014: White Is the New Orange

Update 11/5/14 No storms on the horizon for next week in the West, but check out this model for a “polar express” in the East and Midwest also creating a “blocking pattern” for the West: http://wxbrad.com/massive-storm-in-the-pacific-drives-arctic-outbreak-into-the-u-s-next-week/ Massive Storm in the Pacific drives Arctic Outbreak into the U.S Next Week. http://wp.me/p1srzO-1RZ Massive Storm in the Pacific […]

Continue Reading

Bio Investor Forum #2: T-Cell Therapies and Cancer Targets

Genetically Modified T-cells: Gene Therapy Is Back! Here are some quick notes and an overview of the companies at Bio: Immuno-Oncology  is one of the hottest new areas of biopharmaceutical development and on October 7  BIO presented a Therapeutic Session on “T-Cell Therapies: Best Bets in Pushing Down the Cost Curve and Prioritizing Cancer Targets”. […]

Continue Reading

Rayno Life Science Performance: Up 21%+ YTD…FBT, GILD, ILMN

Biotechs Continue To Lead The Market NASDAQ registered its third day of gains up 2.38% for the period and life science stocks followed. The NAZ is now up 3.34% YTD. Biotech stocks are way ahead of the market  YTD with our top ETF pick (FBT) up 31% YTD and 3.66% over five days.The IBB is […]

Continue Reading

Trading A Bottom in Small Cap Life Science Stocks …Update 11/5

11/15/14  Speculative Small Cap Stocks-Stay Away Unless Your Are A Trader Nice profits were booked on our recent small cap picks but today the sell-off was “pronounced”: Celldex (CLDX) was down 21% to $13.10 after hitting a high near $18 on October 31. GlycoMimetics (GLYC) was up 2.14% to $7.62 more than 15% above our […]

Continue Reading

Technical Damage to Market is Significant: Fear Factor Rules..Update 10/14

10/14 …Update 3:10p Here come the sellers late in the day on schedule. Investors are trying to hold the fort. Oil down, treasuries up, JPMorgan misses off 0.43%. XLE off 0.57%, Gold steady at 1233, biotechs mixed but GILD down 5%, industrials and technology in the green. Germany slashes growth forecast. FINVIZ.com – Stock Screener […]

Continue Reading